6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	CCC Intelligent Solutions Holdings Inc. Announces First Quarter 2026 Financial Results
Just now	Belden to Acquire RUCKUS Networks from Vistance Networks, Accelerating its Transformation into a Full-Stack Networking Solutions Provider
Just now	Crocs, Inc. Reports Better-Than-Expected First Quarter 2026 Results And Raises Full-Year Outlook
Just now	OTC Markets Group Welcomes Stanmore Resources Limited to OTCQX
Just now	Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

About

Alaunos Therapeutics Inc (NASDAQ:TCRT) — investor relations, events, news, and company updates on 6ix.

Latest News

Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders

Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)

Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives

Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives

Financials

Revenue

$5 K

Market Cap

$6.41 M

EPS

-2.20

Community Chat

Ask AI